DRUG-INDUCED LIVER INJURIES


Cite item

Full Text

Abstract

The article discusses the problem of drug-induced liver injuries due to toxic effects of drugs, dietary supplements and alternative medicine resources. Options of drug-induced liver injuries, principles of diagnosis, treatment and prevention of hepatotoxicity are represented. Physicians awareness has a great importance for the prevention of hepatotoxicity, because the timely cessation of drug allows to avoid more severe liver injury. Investigations of the prophylactic effect of some drugs that have a beneficial effect on liver function, particularly S-adenosyl-L-methionine (ademethionine) and ursodeoxycholic acid, are most promising.

References

  1. Ostapowicz G, Fontana R, Schiodt F, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
  2. Russo M, Galanko J, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10(8):1018-23.
  3. Teschke R. [Drug-induced liver diseases]. Z Gastroenterol 2002;40(5):305-26.
  4. Лопаткина Т.Н., Бурневич Э.З. Лекарственные поражения печени. В кн. Н.А. Мухин (ред.). Практическая гепатология. М., 2004. С. 133-6.
  5. Lee W. Drug-induced hepatotoxicity. N Engl J Med, 2003;349:474-85.
  6. Robin M-A, Le Roy M, Descatoire V, et al. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol 1997;26:23-30.
  7. Villeneuve J, Pichette V. Cytochrome P450 and liver diseases. Curr Drug Metab 2004;5(3): 273-82.
  8. Jaeschke H, Gores G, Cederbaum A. et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;66:166-76.
  9. Reed J. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001; 7:314-19.
  10. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin. Liver Dis 2001;21:57-69.
  11. DeLeve L, Shulman H, McDonald G. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27-42.
  12. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195-206.
  13. Gunawan B, Kaplowitz N. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev 2004;36(2):301-12.
  14. Andrade R, Camargo R, Lucena M, et al. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 2004;3(4):329-44.
  15. Dart R, Horowitz R, McDonald F. Lessons from experience with acetaminophen overdose. OTC analgesic use. Special report 1996;75-84.
  16. Prescott L. Paracetamol. A critical bibliographic review. Taylor & Francis Ltd 1996.
  17. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5.
  18. Nolan C, Goldberg S, Buskin S. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014-18.
  19. Sulkowski M. Hepatotoxicity associated with antiretroviral therapy containin HIV-1 protease inhibitors. Semin Liver Dis 2003;23(2):183-94.
  20. King P, Perry M. Hepatotoxicity of chemotherapy. Oncologist 2001;6(2):162-76.
  21. Smet P. Herbal medicines. N.Engl J Med 20024;347(25):2046-56.
  22. Santini D, Vincenzi B, Massacesi C, et al. S-Аденозилметионин (Гептрал) в лечении поражения печени, вызванного химиотерапией. Anticancer Res 2003;23:5173-80.
  23. Lieber C. S-Adenosyl-L-methionine: its role in the treatment of liverdisorders. Am J Clin Nutr 2002;76:1183-7.
  24. Mato J, Corrales F, Lu S, et al. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002;16:15-26.
  25. Nei S, Signorelli S, Sterna D, et al. Роль адеметионина (S-аденозилметионина) в профилактике холестаза, вызванного циклоспорином. Clin. Drug Invest 2002;22(3):191-5.
  26. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002;22(2):145-55.
  27. Takikawa H, et al. Lessons from ticlopidine-induced liver injury. Hepatol Res 2005;33(3):193-94.
  28. Vincenzi B, Santini D, Frezza AM, et al. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen. Expert Opin Drug Saf 2011;10(3):345-49.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies